Lv7
5008 积分 2021-05-31 加入
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
28天前
已完结
Cervical Cancer
28天前
已完结
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
1个月前
已完结
Neoadjuvant chemotherapy plus cadonilimab followed by extra-fascial hysterectomy for International Federation of Gynecology and Obstetrics stage IB2 cervical cancer: a prospective, multi-center, single-arm, phase 2 trial
1个月前
已关闭
DHRS2 as a Novel Thalidomide Target Regulating Mitophagyand Inflammation in Head and Neck Squamous Cell Carcinoma
1个月前
已完结
HER2-low expression in patients with advanced or metastatic solid tumors
3个月前
已完结
Ivonescimab and other anti-programmed death-1/ligand 1 (PD-(L)1)/vascular endothelial growth factor (VEGF) bispecific antibodies: progress and prospects in cancer therapy
3个月前
已完结
Integrating venetoclax-based targeted and/or immune therapies for chronic lymphocytic leukemia
3个月前
已完结
Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcome analysis of the CLL13/GAIA trial
3个月前
已关闭
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026
3个月前
已完结
皖公网安备34019202002308
